The Aesthetic Show is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
This activity is jointly provided by Global Education Group and Informa Connect.
The Aesthetic Show 2025
June 26-June 29, 2025
Wynn Las Vegas in Las Vegas, NV
Target Audience
This activity has been designed to meet the educational needs of physicians and allied health professionals working directly within medical aesthetics, dermatology, plastic and cosmetic surgery.
Statement of Need/Program Overview
Physicians and professional medical staff practicing aesthetic medicine need the educational tools to acquire the knowledge necessary for effective, safe and high-level patient care. The education of physicians and professional medical staff is essential to providing effective patient care in a medical aesthetic practice. There is a lack of educational conferences where physicians and their entire staff of medical professionals can attend together to learn the same information at the same time via didactic sessions. The Aesthetic Show is designed to bring the latest medical aesthetic knowledge, including plastic surgery, cosmetic surgery and dermatologic procedures, products and technologies together in an interactive format.
Educational Objectives
After completion of this activity, participants will be able to:
Discuss the integration of aesthetic medicine with wellness, longevity and regenerative treatments.
Review current safety, efficacy data, and guidelines for neurotoxins, dermal fillers, and biostimulatory products.
Discuss safe and proper injection techniques with minimal complications and satisfactory patient outcomes
Describe key formulary differences and similarities between currently available injectable products
Identify advanced techniques to inject neurotoxins and dermal filler products
Discuss complications associated with injectables, threads, and energy-based devices using best practice protocols.
Review treatment options to better serve a more diverse range of skin types
Identify appropriate techniques in hair restoration based on current evidence, patient needs, and clinical innovation.
Evaluate emerging trends and innovations in injectable products for aesthetic medicine.
Discuss options for minimally invasive body shaping, contouring, fat reduction, and cellulite treatment options
Identify the role of hormone-based therapies in anti-aging treatments and patient care
Review available treatment and therapy options to improve genital form and function
Review the most recent developments, clinical investigations, and scientific endorsement of regenerative treatments
Explain safe techniques for dispensing physician-grade skincare as a pre- and post-treatment therapy
Explain the role of PRP, exosomes and stem cell-based therapies in regenerative aesthetics.
Outline current safety and efficacy data for thread lift/suspension suture products and procedures
Identify the mechanism of action of thread lift/suspension suture products
Explain the benefits, uses, and risks of available energy-based devices in aesthetic procedures.
Identify new methods and insights to improve or enhance your current energy-based treatment protocols and outcomes
Discuss safe and proper microneedling and intradermal delivery techniques for various indications and on skin of color for minimal complications and satisfactory outcomes
Integrate diagnostic tools (ultrasound, labs, genomic and microbiome testing) to personalize treatments in aesthetic practice.
Design and implement comprehensive treatment plans that combine multiple modalities for optimal results.
Faculty
Please return to see the list of faculty and their disclosures.
Program Agenda
Please return to see the program agenda.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Informa Connect. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this live activity for a maximum of 21.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Global Education Group is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 21.0 contact hours including 0.0 pharmacotherapeutic contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or [email protected].
Instructions to Receive Credit
In order to receive credit, participants must attend the meeting, and score at least a 70% on the posttest and submit it, along with the credit application and evaluation. A link to complete the posttest and evaluation will be emailed to participants following the completion of the meetings. Statements of credit will be emailed within 4-6 weeks following completion of the survey. If you do not receive a link following the meeting, please contact Lauren Sinclair at [email protected].
Fee Information & Refund / Cancellation Policy
Click here for Fee Information
Click here for the Cancellation Policy
Disclosure of Relevant Financial Relationships
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
Please return for a list of faculty and disclosures.
The planners and managers have the following relevant financial relationships with ineligible companies:
The planners and managers at Global Education Group have no relevant financial relationships to disclose.
The planners and managers at Informa Connect have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Informa Connect do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.